Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Cadila Healthcare

    Tag: cadila healthcare

    You Searched For "Cadila Healthcare"
    Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India

    Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India

    Medical Dialogues Bureau5 Aug 2019 10:00 AM IST
    Saroglitazar Magnesium was launched in India during September 2013, under the brand name 'Lipaglyn', for the treatment of hypertriglyceridemia and...
    Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection

    Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection

    Medical Dialogues Bureau1 Aug 2019 9:25 AM IST
    "The United States Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredient manufacturing facility located at...
    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Medical Dialogues Bureau25 July 2019 11:23 AM IST
    In a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US

    Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US

    Medical Dialogues Bureau21 July 2019 10:00 AM IST
    The product is a generic version of Adderall XR capsules and will be manufactured at Nesher Pharmaceuticals' manufacturing facility at St Louis in the...
    Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila

    Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila

    Medical Dialogues Bureau18 July 2019 9:17 AM IST
    "Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Meghna A Singhania23 Jun 2019 4:57 PM IST
    New Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
    Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

    Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

    Medical Dialogues Bureau18 Jun 2019 1:57 PM IST
    New Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action...
    CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

    CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details

    Farhat Nasim6 Jun 2019 12:11 PM IST
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
    Cadila Healthcare gets 11 USFDA observations for St Louis facilities

    Cadila Healthcare gets 11 USFDA observations for St Louis facilities

    Farhat Nasim3 Jun 2019 5:23 PM IST
    The United States Food and Drug Administration (USFDA) inspected the manufacturing facilities of Nesher Pharmaceuticals (USA) LLC located at St Louis,...
    Cadila Healthcare posts Q4 net profit of Rs 460 crore

    Cadila Healthcare posts Q4 net profit of Rs 460 crore

    Medical Dialogues Bureau30 May 2019 9:15 AM IST
    The consolidated financial statements for the quarter and the year ended March 31, 2019, including the operations of Heinz India Pvt Ltd (HIPL) for...
    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Farhat Nasim4 May 2019 10:00 AM IST
    The US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok